Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTP1 | P09211 | 20/20 | 0.57 |
| ▸ | GSTM2 | P28161 | 20/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26797771 | 1.00 | GSTP1 (0.57) | GSTP1GSTM2 | |
| SCHEMBL26797780 | 0.89 | GSTP1 (0.57) | GSTP1GSTM2 | |
| SCHEMBL30599546 | 0.87 | GSTP1 (0.57) | GSTP1GSTM2 | |
| SCHEMBL26797772 | 0.87 | GSTP1 (0.57) | GSTP1GSTM2 | |
| SCHEMBL26797778 | 0.87 | GSTP1 (0.70) | GSTP1GSTM2 | |
| SCHEMBL26797775 | 0.87 | GSTP1 (0.57) | GSTP1GSTM2 | |
| SCHEMBL3712753 | 0.76 | GSTP1 (0.65) | GSTP1GSTM2 | |
| SCHEMBL14959168 | 0.74 | GSTP1 (0.64) | GSTP1GSTM2 | |
| SCHEMBL26797867 | 0.72 | GSTP1 (0.40) | GSTP1GSTM2 | |
| SCHEMBL26797894 | 0.72 | GSTP1 (0.40) | GSTP1GSTM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230365516-A1 | COMPOUNDS FOR CANCER THERAPY AND IMAGING | WASHINGTON UNIVERSITY | 2023-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230365516-A1 | COMPOUNDS FOR CANCER THERAPY AND IMAGING | MKI67, VHL, TP53 | GSTP1 864/4885GSTM2 1336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.